IPD - L-Dex® granted reimbursement status for all cancer related...

  1. Freehold
    24,192 Posts.
    lightbulb Created with Sketch. 5565
    clock Created with Sketch.
    03/09/14
    11:12
    Post #: 13916787
    IPD - L-Dex® granted reimbursement status for all cancer related lymphoedema

    HIGHLIGHTS
     Transformational event for ImpediMed, reimbursement status for use of L-Dex across all relevant cancer types
     Expands L-Dex addressable market opportunity to over US$ 350 million per annum
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
NEWS Join our Daily Newsletter to gain exclusive insights into HotCopper!
right-arrow Created with Sketch.
CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.

Top Stories

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.